Literature DB >> 12726723

Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination.

William A Meier1, Judy Galeota, Fernando A Osorio, Robert J Husmann, William M Schnitzlein, Federico A Zuckermann.   

Abstract

Infection of swine with virulent porcine reproductive and respiratory syndrome (PRRS) virus induced a rapid, robust antibody response that comprised predominantly nonneutralizing antibodies and waned after approximately 3 months. In contrast, the initial onset of virus-specific interferon (IFN)-gamma-secreting cells (SC) in the pig lymphocyte population remained at a fairly low level during this period and then increased gradually in frequency, plateauing at 6 months postinfection. A similar polarization of the host humoral and cellular immune responses was also observed in pigs immunized with a PRRS-modified live virus (MLV) vaccine. Even coadministration of an adjuvant that enhanced the immune response to a pseudorabies (PR) MLV vaccine failed to alter the induction of PRRS virus-specific IFN-gamma SC (comprising predominantly CD4/CD8 alpha double positive memory T cells with a minority being typical CD4(-)/CD8 alpha beta(+) T cells) and the generation of neutralizing antibodies. Moreover, unlike inactivated PR virus, nonviable PRRS virus did not elicit virus-neutralizing antibody production. Presumably, an intrinsic property of this pathogen delays the development of the host IFN-gamma response and preferentially stimulates the synthesis of antibodies incapable of neutralization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726723     DOI: 10.1016/s0042-6822(03)00009-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  110 in total

1.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions.

Authors:  Zhi Sun; Zhenhai Chen; Steven R Lawson; Ying Fang
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Concurrent vaccination of boars with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) reduces seminal shedding of type 1 and type 2 PRRSV.

Authors:  Jiwoon Jeong; Changhoon Park; Ikjae Kang; Su-Jin Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

4.  A comparison of the humoral and cell-mediated response of pigs experimentally infected with either influenza or PRRS viruses.

Authors:  M Ferrari; P Candotti; G Lombardi; M Amadori; S Dotti; S Guana; S Petrini
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

5.  Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.

Authors:  Jiwoon Jeong; Changhoon Park; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

Review 6.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

Review 7.  Impact of PRRSV on activation and viability of antigen presenting cells.

Authors:  Irene M Rodríguez-Gómez; Jaime Gómez-Laguna; Librado Carrasco
Journal:  World J Virol       Date:  2013-11-12

8.  Role of Toll-like receptors in activation of porcine alveolar macrophages by porcine reproductive and respiratory syndrome virus.

Authors:  Laura C Miller; Kelly M Lager; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

9.  Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.

Authors:  Yijun Du; Jing Qi; Yu Lu; Jiaqiang Wu; Dongwan Yoo; Xing Liu; Xiumei Zhang; Jun Li; Wenbo Sun; Xiaoyan Cong; Jianli Shi; Jinbao Wang
Journal:  Virus Genes       Date:  2012-07-28       Impact factor: 2.332

10.  Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.

Authors:  Sarah Costers; David J Lefebvre; Bruno Goddeeris; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.